New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 10, 2013
13:04 EDTBRLI, FNSR, KMX, HMA, BIDU, TITN, CIEN, FAST, ADTNOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday following the unexpected early release of the minutes from the Fed's last rate setting meeting in March. The move higher has pushed the S&P above its all-time closing high, which was established last week, and has seen it set a new all-time intraday record as well. In addition to the Fed minutes, the President unveiled a budget proposal that calls for tough entitlement cuts, but those come paired with increased revenues, and China unexpectedly reported a trade deficit caused by higher than expected imports... ECONOMIC EVENTS: In the U.S., the Federal Reserve decided to release the minutes from it last Federal Open Market Committee meeting at 9:00 am ET, which was five hours earlier than scheduled, because they were leaked yesterday to trade groups and some members of Congress. The minutes showed continued discussion over the costs and benefits of the Fed's bond-buying program, with several members saying it would "probably be appropriate to slow purchases later in the year and to stop them by year-end." However, many on the Street noted that the minutes were for a meeting that occurred prior to last Friday's disappointing monthly jobs report. Also, President Obama sent a $3.77T spending plan to Congress in a bid to revive deficit-reduction talks. In China, a rare trade deficit of $880M was reported for March, as imports surged 14.1% from a year earlier, outpacing a 10% rise in exports. Also of note, the World Trade Organization slashed its forecast for global trade growth in 2013 to 3.3% from its prior call for 4.5% growth, and S&P revised its outlook on Cyprus to Stable from Negative... COMPANY NEWS: Earnings season picked up a little bit of steam, with reports from ADTRAN (ADTN) and CarMax (KMX) sending their shares higher, while Titan Machinery (TITN) and Fastenal (FAST) declined following their quarterly results announcements... MAJOR MOVERS: Among the notable gainers was Baidu (BIDU), which rose over 6% following an upgrade to Buy from Hold at 86 Research. Also trading higher were a number of ADTRAN's peers, including Finisar (FNSR), up nearly 7%, and Ciena (CIEN), up about 6%, following the telecommunication equipment provider's better than expected report. Among the noteworthy losers were Health Management Associates (HMA), which fell 17% after its preliminary view of its quarterly results fell short of expectations, and Bio-Reference Labs (BRLI), which slid 7% in an apparent delayed reaction to a "whistleblower" suit filed against it last week but widely circulated today... INDICES: Near 1 pm ET, the Dow was up 147.54, or 1.01%, to 14,821.00; the Nasdaq was up 58.03, or 1.79%, to 3,295.89; and the S&P 500 was up 19.43, or 1.24%, to 1,588.04.
News For ADTN;TITN;KMX;FAST;BIDU;FNSR;CIEN;HMA;BRLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2015
14:50 EDTCIENNotable companies reporting before tomorrow's open
Subscribe for More Information
August 31, 2015
14:45 EDTCIENCiena volatility elevated into Q3 and outlook
Subscribe for More Information
05:44 EDTBIDUBaidu upgraded to Buy from Hold at Jefferies
Jefferies analyst Cynthia Meng upgraded Baidu to Buy saying concerns around search ad spending are overdone. Recent channel checks with top ad agents indicated "strong traction" for performance-based ads, with any cuts to ad budgets being mostly offset by more allocation toward key word search from display ads, Meng tells investors in a research note. At current levels, Meng believes Baidu shares have largely priced in reduced earnings growth expectations. She keeps a price target of $210 for the stock. The Chinese search giant closed Friday up 7c to $152.13.
August 28, 2015
07:17 EDTCIENCoomunication tech stock drop likely a buying opportunity, says Wells Fargo
Subscribe for More Information
August 26, 2015
17:16 EDTCIENEXFO Inc. names Philippe Morin as COO
EXFO Inc. (EXFO) announced that Philippe Morin will be joining the company as COO in early November. Morin, who has more than 25 years of experience in the telecommunications industry, will leave Ciena (CIEN) as Senior Vice-President of Worldwide Sales and Field Operations on October 31. Previously, he was Ciena's Senior Vice-President of the Global Products Group and held a number of leadership roles at Nortel Networks including President of Metro Ethernet Networks, Vice-President and General Manager of Optical Networks, as well as having held positions in sales, marketing and product management in North America and Europe.
10:00 EDTCIENOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:15 EDTBRLIOPKO CEO Frost issues letter to shareholders on Bio-Reference deal
OPKO Health (OPK) chairman and CEO Phillip Frost released a letter to shareholders regarding the recently announced acquisition of Bio-Reference Laboratories (BRLI). "The strategy behind the recent Bio-Reference acquisition is twofold. First, it is a business whose revenues and profits have grown consistently since its launch by Dr. Marc Grodman in the 1980's, primarily through organic growth, to become the third largest full service reference laboratory in the United States," the letter reads. "It has built a reputation of innovation with recognized franchises in women's health, cancer and, more recently, genetics, helping physicians worldwide to diagnose rare genetic disorders and to identify special features of a patient's genetic material to select more effective chemotherapy. Second, it provides an infrastructure for marketing and sales that reaches approximately 10M patients a year." The letter adds that the 4Kscore test confirms elevated PSA tests have reduced costs by roughly $1B and, if the costs of downstream treatment interventions are also considered, there could be $2.5B additional annual savings to the U.S. health care system. "Among the many compelling reasons for the acquisition, we believe Bio-Reference will greatly accelerate the commercial success of the 4Kscore test," the letter continues. "Bio-Reference has the capacity to dramatically increase the number of 4Kscore tests done each day. They provide national marketing and distribution with a large client services group and a large dedicated sales force that already have strong relationships with primary care physicians. Bio-Reference has over 1,200 phlebotomists and 180 blood-draw centers around the country that can facilitate patient access. Finally, Bio-Reference has robust billing operations and a seasoned national reimbursement team that participates in almost every major commercial insurance plan. Bio-Reference has the expertise and extensive infrastructure to help make the 4Kscore test the new standard for identifying aggressive prostate cancer in men with a suspicious PSA." To close the letter, Frost wrote, "Given Bio-Reference's historical seasonal trends, we expect the second half of 2015 to show continuing growth in earnings and profits. We further expect that the contributions of Bio-Reference, FineTech and EirGen, will create positive EBITDA, or earnings before interest, income taxes, depreciation and amortization, for OPKO. Finally, we expect to continue to invest in research and development activities which, if successful, will result in ongoing improvement of our financial performance."
09:02 EDTCIENCiena says 5430 Packet Optical Platform being deployed by SK Telecom
Subscribe for More Information
08:32 EDTADTNADTRAN helps Twin Valley deliver gigabit service to smart rural communities
Subscribe for More Information
08:15 EDTFASTEmerson reports supports estimate for muted Fastenal growth, says William Blair
Subscribe for More Information
06:47 EDTCIENCiena upgraded to Outperform from Market Perform at Raymond James
Subscribe for More Information
August 24, 2015
09:45 EDTFASTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:59 EDTFASTFastenal downgraded to Neutral from Outperform at Baird
Baird downgraded Fastenal to Neutral from Outperform as US economic trends are progressively later-cycle, raising overall risk profiles for distributors with industrial exposure. Baird lowered its price target to $44 from $45 on Fastenal shares.
05:57 EDTBIDUStocks with implied volatility below IV index mean; BIDU GOOG
Stocks with implied volatility below IV index mean; Baidu (BIDU) 41, Google (GOOG) 31 according to iVolatility.
August 20, 2015
17:19 EDTBRLIInnospec to replace Bio-Reference Labs in S&P 600 as of 8/21 close
OPKO Health (OPK) is acquiring Bio-Reference Laboratories (BRLI) in a deal that closed August 20.
10:43 EDTBRLIOPKO Health completes acquisition of Bio-Reference Labs
Subscribe for More Information
07:20 EDTBIDUCitigroup to hold a conference
Hong Kong / China Corporate Day is being held in Hong Kong on August 20.
August 19, 2015
14:35 EDTBRLIBio-Reference Labs to host special shareholder meeting
Special Shareholder Meeting to vote on the proposed merger with OPKO Health will be held in Mahwah, New Jersey on August 20 at 9 am.
09:03 EDTCIENCiena chosen by TCR Telecom to support 'Porto Maravilha' project
Subscribe for More Information
07:34 EDTBIDUChinaNet Online announces partnership with Baidu
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use